Bio-nFeR demonstrated mutation-independent therapeutic activity in xenografts of human melanoma, lung, and colorectal cancer, with a specific action towards cancer stem cells (CSCs) populations, i.e. ALDH1+ cells in lung cancer and CD44v6+ cells in melanoma and colorectal cancer [9]. This evidence concerns the gene ALDH1A1 and melanoma.